Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458767 · ClinicalTrials.gov registry record · NA
A Cognitive Self-Management Intervention for Persons With Multiple Sclerosis: Adapting Web-based Technology
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03458767: Completed NA study, sponsored by University of Texas at Austin.
NCT03458767 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03458767, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Development and pilot testing of a cognitive self-management intervention for persons with multiple sclerosis (PwMS) emphasizing physical activity (PA) delivered via web-based video conference.
Primary Outcome
Test of vocabulary knowledge
Interventions
- BEHAVIORAL Eight weekly 90-minute group educational sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2018-06-01 |
| Phase | NA |
What the finished NCT03458767 record still lists
NCT03458767 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Eight weekly 90-minute group educational sessions is the first listed.
NCT03458767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03458767 about?
NCT03458767 is a clinical study titled "A Cognitive Self-Management Intervention for Persons With Multiple Sclerosis: Adapting Web-based Technology". Development and pilot testing of a cognitive self-management intervention for persons with multiple sclerosis (PwMS) emphasizing physical activity (PA) delivered via web-based video conference.
What is the current status of trial NCT03458767?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-10-09. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT03458767?
The interventions under investigation include: Eight weekly 90-minute group educational sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03458767?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03458767's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI